Skip to content

MAXIPHARMA

Active
Private limited companyfounded 1997active for 29 yearsRue de la Neuville 66, 6000 Charleroi, BelgiumKBO/BCE: BE 0460.509.874
Summary

MAXIPHARMA has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €227,467 and a net result of €89,731. Equity is shrinking by about 7% per year across the filed financial years. Its solvency ranks better than 91% of 22,513 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Financials · financial year 2025, micro format

2025 annual accounts filed late (30 days) Filed on 30 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00454480.

Equity
€227,467▲ 65.1%
2024 · €137,736
Total assets
€269,211▲ 80.7%
2024 · €149,012
Net result
€89,731
2024 · -€9,992
Working capital
€227,467▲ 128%
2024 · €99,880
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result returns to profit in 2025: €127,290 after a loss of €9,079 in 2024, the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€127,290 2025 Net result€89,731 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€8,597--€96-€4,853▼ 4,934%€3,703€1,611▼ 56.5%-€6,948-€9,079▼ 30.7%€127,290
Net result€7,846--€1,204-€5,995below the sector's middle half▼ 398%€2,592within the sector's middle half€429within the sector's middle half▼ 83.4%-€8,390below the sector's middle half-€9,992below the sector's middle half▼ 19.1%€89,731above the sector's middle half
Equity€236,446-€226,241▼ 4.3%€210,246above the sector's middle half▼ 7.1%€197,839above the sector's middle half▼ 5.9%€183,268above the sector's middle half▼ 7.4%€154,878above the sector's middle half▼ 15.5%€137,736above the sector's middle half▼ 11.1%€227,467above the sector's middle half▲ 65.1%
Total assets€256,358-€266,785▲ 4.1%€259,982within the sector's middle half▼ 2.6%€232,519within the sector's middle half▼ 10.6%€217,516within the sector's middle half▼ 6.5%€191,492within the sector's middle half▼ 12.0%€149,012within the sector's middle half▼ 22.2%€269,211within the sector's middle half▲ 80.7%
Debt€19,913-€40,544▲ 104%€49,736▲ 22.7%€34,680▼ 30.3%€34,249▼ 1.2%€36,614▲ 6.9%€11,275▼ 69.2%€41,744▲ 270%
Working capital€169,698-€155,615▼ 8.3%€148,561above the sector's middle half▼ 4.5%€140,487above the sector's middle half▼ 5.4%€131,668above the sector's middle half▼ 6.3%€110,260above the sector's middle half▼ 16.3%€99,880above the sector's middle half▼ 9.4%€227,467above the sector's middle half▲ 128%
Solvency92.2%-84.8%▼ 7.4pp80.9%above the sector's middle half▼ 3.9pp85.1%above the sector's middle half▲ 4.2pp84.3%above the sector's middle half▼ 0.8pp80.9%above the sector's middle half▼ 3.4pp92.4%above the sector's middle half▲ 11.6pp84.5%above the sector's middle half▼ 7.9pp
Current ratio9.52-5.87▼ 3.654.41above the sector's middle half▼ 1.465.53above the sector's middle half▲ 1.124.99above the sector's middle half▼ 0.554.01above the sector's middle half▼ 0.989.86above the sector's middle half▲ 5.856.45above the sector's middle half▼ 3.41
Return on assets (ROA)3.1%--0.5%▼ 3.5pp-2.3%below the sector's middle half▼ 1.9pp1.1%within the sector's middle half▲ 3.4pp0.2%within the sector's middle half▼ 0.9pp-4.4%below the sector's middle half▼ 4.6pp-6.7%below the sector's middle half▼ 2.3pp33.3%above the sector's middle half▲ 40.0pp
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €269,211
Equity €227,467 ▲ 65.1%
Debt €41,744 ▲ 270%
Debt's share of the balance-sheet total rises from 7.6% to 15.5%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
Debt to equity
0.18▲
2024 · 0.08
ROE
39.4%▲
2024 · -7.3%
Debt ≤ 1 year
€41,744▲
2024 · €11,275
Income taxes
€36,646▲
2024 · €128
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 31,372 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 93.5% are still going.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.5% went bankrupt
5.9% stopped otherwise
93.5% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 31,372 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet Code20242025
Assets
Total assets20/58€149,012€269,211▲
Fixed assets21/28€37,856-
Tangible fixed assets22/27€37,856-
Land and buildings22€37,856-
Current assets29/58€111,155€269,211▲
Stocks and contracts in progress3€5,485-
Stocks30/36€5,485-
Amounts receivable within one year40/41€17,072€1,086▼
Trade receivables40€11,250€162▼
Other amounts receivable41€5,821€924▼
Cash at bank and in hand54/58€86,587€267,253▲
Deferred charges and accrued income490/1€2,012€871▼
Equity and liabilities
Total equity and liabilities10/49€149,012€269,211▲
Equity10/15€137,736€227,467▲
Contributions10/11€6,197€6,197=
Reserves13€131,539€221,270▲
Non-distributable reserves130/1€1,859€1,859=
Reserves not available under the articles1311€1,859€1,859=
Distributable reserves133€129,680€219,411▲
Amounts payable17/49€11,275€41,744▲
Amounts payable within one year42/48€11,275€41,744▲
Trade debts44€4,060€1,665▼
Suppliers440/4-€1,665
Bills of exchange payable441€4,060-
Taxes, remuneration and social security45€2,211€37,415▲
Taxes450/3€2,211€37,415▲
Other amounts payable47/48€5,005€2,664▼
Income statement Code20242025
Non-recurring operating income76A-€169,644
Remuneration, social security and pensions62€764-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6,762-
Other operating charges640/8€2,765€2,331▼
Gross operating margin9900€1,212€129,621▲
Operating profit (loss)9901-€9,079€127,290▲
Financial income75/76B€570€443▼
Recurring financial income75€570€443▼
Financial charges65/66B€1,355€1,356▲
Recurring financial charges65€1,355€1,356▲
Profit (loss) for the period before taxes9903-€9,864€126,377▲
Income taxes67/77€128€36,646▲
Profit (loss) for the period9904-€9,992€89,731▲
Profit (loss) for the period to be appropriated9905-€9,992€89,731▲
Appropriation of the result
Profit (loss) to be appropriated9906-€9,992€89,731▲
Transfer from equity791/2€17,142-
Transfer to equity691/2-€89,731
To other reserves6921-€89,731
Profit to be distributed694/7€7,150-
Return on contributions (dividend)694€7,150-

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Non-recurring operating income76A-------€169,644-
Remuneration, social security and pensions62------€764--
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8,542€9,927€11,402€8,794€8,213€8,213€6,762--
Other operating charges640/8---€2,628€2,702€2,778€2,765€2,331▼ 15.7%
Gross operating margin9900€19,274€12,205€9,303€15,125€12,526€4,042€1,212€129,621▲ 10,597%
Operating profit (loss)9901€8,597-€96-€4,853€3,703€1,611-€6,948-€9,079€127,290-
Financial income75/76B---€243€1€189€570€443▼ 22.3%
Recurring financial income75€527€405€397€243€1€189€570€443▼ 22.3%
Financial charges65/66B---€1,243€1,071€1,292€1,355€1,356▲ 0.1%
Recurring financial charges65€1,228€1,449€1,430€1,182€1,071€1,259€1,355€1,356▲ 0.1%
Non-recurring financial charges66B---€62-€33---
Profit (loss) for the period before taxes9903€7,846-€1,141-€5,886€2,702€541-€8,051-€9,864€126,377-
Income taxes67/77-€64€109€110€112€339€128€36,646▲ 28,529%
Profit (loss) for the period9904€7,846-€1,204-€5,995€2,592€429-€8,390-€9,992€89,731-
Profit (loss) for the period to be appropriated9905€7,846-€1,204-€5,995€2,592€429-€8,390-€9,992€89,731-
Line20182019202020212022202320242025Change
Assets
Total assets20/58€256,358€266,785€259,982€232,519€217,516€191,492€149,012€269,211▲ 80.7%
Fixed assets21/28€66,747€79,239€67,837€61,043€52,831€44,618€37,856--
Tangible fixed assets22/27€66,747€79,239€67,837€61,043€52,831€44,618€37,856--
Land and buildings22---€54,955€49,193€43,430€37,856--
Furniture and vehicles24---€6,088€3,638€1,188---
Current assets29/58€189,611€187,546€192,145€171,476€164,686€146,874€111,155€269,211▲ 142%
Stocks and contracts in progress3€39,085€41,141€41,251€38,333€34,535€27,409€5,485--
Stocks30/36---€38,333€34,535€27,409€5,485--
Amounts receivable within one year40/41€30,735€25,433€17,864€20,321€23,457€19,973€17,072€1,086▼ 93.6%
Trade receivables40---€11,237€16,655€17,080€11,250€162▼ 98.6%
Other amounts receivable41---€9,085€6,802€2,892€5,821€924▼ 84.1%
Cash at bank and in hand54/58€118,796€119,016€129,719€111,026€104,847€95,623€86,587€267,253▲ 209%
Deferred charges and accrued income490/1---€1,796€1,847€3,869€2,012€871▼ 56.7%
Equity and liabilities
Total equity and liabilities10/49€256,358€266,785€259,982€232,519€217,516€191,492€149,012€269,211▲ 80.7%
Equity10/15€236,446€226,241€210,246€197,839€183,268€154,878€137,736€227,467▲ 65.1%
Contributions10/11€6,197€6,197-€6,197€6,197€6,197€6,197€6,197=
Reserves13€230,248€220,044€204,049€191,641€177,070€148,681€131,539€221,270▲ 68.2%
Non-distributable reserves130/1---€1,859€1,859€1,859€1,859€1,859=
Reserves not available under the articles1311---€1,859€1,859€1,859€1,859€1,859=
Distributable reserves133---€189,782€175,211€146,821€129,680€219,411▲ 69.2%
Amounts payable17/49€19,913€40,544€49,736€34,680€34,249€36,614€11,275€41,744▲ 270%
Amounts payable after more than one year17-€8,613€6,152€3,691€1,231----
Financial debts170/4---€3,691€1,231----
Amounts payable within one year42/48€19,913€31,931€43,584€30,989€33,018€36,614€11,275€41,744▲ 270%
Current portion of amounts payable after more than one year42---€2,461€2,461€1,231---
Trade debts44€7,044€13,939€23,965€6,826€7,004€8,480€4,060€1,665▼ 59.0%
Suppliers440/4---€2,661€3,249€4,680-€1,665-
Bills of exchange payable441---€4,165€3,755€3,800€4,060--
Taxes, remuneration and social security45---€9,810€9,221€10,572€2,211€37,415▲ 1,592%
Taxes450/3---€7,614€7,065€8,331€2,211€37,415▲ 1,592%
Remuneration and social security454/9---€2,196€2,156€2,241---
Other amounts payable47/48---€11,892€14,332€16,332€5,005€2,664▼ 46.8%
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€7,846-€1,204-€5,995€2,592€429-€8,390-€9,992€89,731-
+ Depreciation and write-downs630€8,542€9,927€11,402€8,794€8,213€8,213€6,762--
Operating cash flow (approximation)€16,389€8,722€5,407€11,386€8,642-€177-€3,230€89,731-
Investment in fixed assets (approximation)--€22,419€0-€2,000€0€0€0--
Change in cash-€220€10,703-€18,694-€6,179-€9,224-€9,037€180,667-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 29 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 30-08-2026 2026-00454480
31-12-2024 micro format 28-08-2025 2025-00462277
31-12-2023 micro format 29-08-2024 2024-00404611
31-12-2022 micro format 29-08-2023 2023-00421295
31-12-2021 micro format 25-08-2022 2022-20379486
31-12-2020 micro format 25-08-2021 2021-52500336
31-12-2019 micro format 11-09-2020 2020-52700384
31-12-2018 micro format 19-08-2019 2019-46900532
31-12-2017 micro format 19-07-2018 2018-34400288
31-12-2016 micro format 31-08-2017 2017-52400309

Show all 29 filings

Similar companies · same sector, comparable size

Of the 5,202 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,874. 3,546 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.